Background:
Introduction
Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterised by impaired social and communication skills, and stereotyped and repetitive behaviours. ASD has a prevalence of 1% (1) , with symptoms typically starting in early childhood. Twin studies estimate the heritability of ASD at between ~65-90% (2, 3), demonstrating that genetic differences play an important role in the development of ASD. Common genetic variants conferring individually weak effects are an important component of ASD liability, with the most recent SNP-heritability estimate for ASD being 11.8% on a liability scale (assuming prevalence of 1.2%) (4).
Genome-wide association studies (GWAS) are a powerful approach for understanding the role of common alleles in the genetic aetiology of traits and disorders, and have provided several insights into the aetiology of ASD. The most recent and largest ASD GWAS including 18,381 ASD cases and 27,969 controls reported three independent loci achieving genome-wide significance (4) . Genes associated with ASD were highlighted through proximity to genome-wide significant loci and via joint statistical analysis of variants within gene regions. However, a variant's proximity to a gene is only one metric for illuminating its functional consequence and the nearest gene often does not drive the association (5).
An additional approach for highlighting genes that underlie a GWAS association is through integration of functional data. For example, Grove et al. used chromatin conformation data to infer whether significant ASD-loci physically interact with the surrounding genes. Alternatively, prior knowledge of variants effecting gene expression, known as expression quantitative trait loci (eQTLs), can be used to infer gene expression changes associated with a given phenotype based on GWAS SNP-effects. This is a powerful approach because association at the vast majority of loci identified through GWAS of complex traits appears to be mediated by altered gene regulation rather than changes in protein coding sequence (6) . Several methods exist for inferring associated differential expression from GWAS summary statistics, including Summary-data-based Mendelian randomization (SMR) (7) , and transcriptome-wide association study (TWAS, as performed by FUSION (8) and MetaXcan (9)). A key distinction between SMR and TWAS is that TWAS considers the joint effect of multiple SNPs on a gene's expression and therefore has greater power than SMR when there are multiple eQTLs for a given gene (9, 10) . In addition to prioritising genes at genome-wide significant loci, TWAS is able to implicate genes in regions containing no genome-wide significant variants. For example, a recent TWAS of schizophrenia identified 157 unique genes as significantly associated, 35 of which were considered as novel as they were >500kb from a genome-wide significant locus (11) .
Furthermore, by indicating how the regulation of the implicated gene is affected by associated genetic variation, such studies can more accurately inform functional follow-up investigations and, potentially, therapeutic strategies.
In this study, we carry out the first TWAS of ASD in order to identify gene expression changes associated with these disorders. Using the ASD TWAS results, and a novel adaptation of established statistical methods, we also test for enrichment within candidate pathways, specific tissues, and at different stages of brain development. Finally, we estimate the proportion of variance in ASD that is attributable to these TWAS observations.
Methods and Materials Datasets
We performed TWAS using the publically available PGC + iPSYCH ASD GWAS summary statistics (4) (See URLs) and 16 sets of gene expression SNP-weights (Table 1) . SNP-weight sets captured gene expression for fetal brain tissue, and brain, blood and adipose tissue in adults. SNP-weights for each gene-tissue pair is referred to as a feature. Fetal brain features were derived using gene expression data collected from brain homogenates from 67 fetuses aged 12-19 weeks post-conception, and genetically-defined to be of European ancestry, collected through the Human Developmental Biology Resource (12) . Common mind Consortium (CMC), Netherlands Twin Registry (NTR), Young Finns Study (YFS), Metabolic Syndrome in Men study (METSIM) and Genotype-Tissue Expression project (GTEx) SNP-weights were downloaded directly from the FUSION/TWAS website (see URLs). Information regarding the analysis of genotypes and gene expression from these datasets has been previously described: CMC (11), NTR, YFS, METSIM (8), GTEx (13), fetal brain (12) . See also Supplementary Information for further details.
TWAS

Defining transcriptome-wide significance
We estimated transcriptome-wide significance as p = 4.25×10 -6 using a permutation procedure to accurately account for the correlation between features within and across SNP-weight sets (See Supplementary Information).
TWAS analysis using FUSION
TWAS analysis was performed using the FUSION software with default settings (see URLs) (8) .
Colocalisation was performed to estimate the posterior probability that GWAS and TWAS associations share a causal SNP. Colocalisation was performed using the coloc R package (14) , In regions containing multiple significant associations, joint analysis was performed to identify conditionally independent associations. This was implemented using FUSION with genes considered in a joint model if the boundaries overlapped ±0.5Mb.
To pool evidence of association for each gene across SNP-weight sets, the multiple degree-offreedom omnibus test was performed using FUSION.
Derivation of non-TWAS informed gene-based statistics
For comparison purposes, MAGMA's gene-based analyses were performed using the ASD GWAS 
TWAS-based enrichment analysis
Analytical procedure TWAS-based enrichment analysis was performed using a novel adaption of a previously established method for GWAS-based enrichment analysis implemented in the software MAGMA (15) . In brief, enrichment analysis was performed using linear mixed model regression of TWAS Z-score on geneset membership, accounting for the correlation between genes due to LD. We analysed TWAS association results from all 16 SNP-weight sets simultaneously to improve genome coverage and reduce the multiple testing burden. The R package lme4qtl was used to fit the linear mixed model
(16). The software used for this analysis is publically available (see URLs). See Supplementary
Information for further details.
Gene-set enrichment analysis
TWAS results were tested for enrichment across 173 candidate gene-sets, including 134 gene-sets relevant to various aspects of nervous system function and development (herein referred to as the central nervous system (CNS) gene-sets), 38 gene-sets that have been previously implicated in ASD specifically (herein referred to as ASD-relevant gene-sets), and a gene-set containing loss of function intolerant genes. The CNS and loss of function gene-sets have been previously described in ref. (17, 18) , and the ASD-related gene-sets have been previously described in ref. (19) . The false-discovery rate (FDR) method was used to correct for multiple testing across all 173 candidate gene sets.
The comparative analysis using non-TWAS informed gene-level associations was also performed using MAGMA.
Gene-property association analysis
Gene-property analysis estimates the relationship between TWAS associations and a continuous gene annotation. Using BRAINSPAN data (20) , a score indicating preferential expression of each gene at 19 developmental stages has been calculated (11) . Using the mixed model approach described above the correlation between preferential expression scores for each developmental period and non-zero association gene Z-scores was then calculated. A significance threshold of p < 0.05/19 was used.
For comparison, gene-property analysis was also performed using the non-TWAS informed genelevel associations in MAGMA using default settings.
SNP-weight set enrichment analysis
We also tested for an enrichment of association across the SNP-weight sets used in this study to evaluate the importance of each tissue or time point in ASD aetiology. Secondary analysis was also performed using only SNP-weight sets for the basal ganglia, to compare each of the three basal ganglia components to one another.
Estimating the proportion of heritability mediated by gene expression
The proportions of ASD heritability accounted for by the TWAS results from each SNP-weight set and all SNP-weight sets combined were estimated using stratified-LD score regression (S-LDSC).
FUSION was used to calculate LD scores files that were restricted to SNPs within the TWAS SNPweights and represented the relationship between each SNP and predicted gene expression. The total heritability of ASD was estimated using standard LDSC. The proportion of SNP-based heritability accounted for by TWAS was calculated as the TWAS-based heritability divided by the SNP-based heritability.
Results
ASD TWAS
Of the 16 SNP-weight sets, 10 revealed transcriptome-wide significant associations, with the fetal brain transcript-level weights returning the most significant associations (5 unique genes) ( Table 1 ).
In total 19 transcriptome-wide significant associations were observed for 14 unique genes (Supplementary Figure 1) . Following conditional analysis, 5 independent transcriptome-wide significant associations were observed ( Table 2 ). Many of these associations achieved transcriptomewide significance across multiple SNP-weight sets (Figure 1 ). Full TWAS association results are in Supplementary Table 1 . Colocalisation posterior probability estimates are available in Supplementary Figure 2 ).
chr17 q21.31:
A cluster of 14 transcriptome-wide significant associations (10 unique genes) were observed within a 1Mb region on chromosome 17 corresponding to an inversion polymorphism that is common in European populations (21) . Table 2 ).
chr2 p25.1:
The transcriptome-wide significant association between PDIA6 and ASD on chromosome 2 is in a genomic region showing minimal evidence of association at the SNP-level, with the minimum p-value being 1.3×10 -4 (+/-2Mbs of PDIA6) (Supplementary Figure 5) . The data best supports Model 4 in which ASD and PDIA6 share a single causal association.
Gene set and property analysis
Full competitive gene-set enrichment results are available in Supplementary Table 3 
Comparison of TWAS results to MAGMA
MAGMA gene association analysis returned similar results to those reported previously by Grove and colleagues (4). Regions containing transcriptome-wide significant associations on chromosome 8, 17
and 20 also contained significant MAGMA-based associations (±500kb of significant TWAS feature), although the different methods often implicated different genes within the same locus (Supplementary   Tables 4 and 5 , Supplementary Figures 7-12 ). The only transcriptome-wide significant locus in which MAGMA identified no significant associations was that surrounding PDIA6 on chromosome 2.
MAGMA identified three loci containing significant genes that contained no TWAS significant genes. 
Discussion
This is the first study to infer differential gene expression/splicing associated with ASD using the TWAS method and has provided several novel insights into the aetiology of ASD.
This study has demonstrated that the previously reported genome-wide significant locus spanning multiple genes within the locus at 20-21 Mb of chromosome 20 is linked to significant differential expression and splicing of the gene XRN2. Functionally agnostic gene-based analysis in MAGMA also identifies XRN2 as significant, as reported in this study and previously by Grove and colleagues (4) . Moreover, a recent study reported evidence that ASD associated SNPs in this region colocalise with several DNA methylation sites (24) , although the consequence of this methylation on surrounding gene expression is unknown. Our data point to differential expression of XRN2 in the blood and differential splicing in the prefrontal cortex. XRN2 is an essential nuclear 5'→3' exoRNase with a multitude of functions in the processing and regulation of RNA molecules. XRN2 has been identified as an essential gene for the survival of multiple human cell lines (25) (26) (27) , and individuals diagnosed with ASD have been shown to have an increased number of deleterious mutations among essential genes (28), again supporting a role for XRN2 in ASD aetiology.
This study also highlighted 13 transcriptome-wide significant genes outside loci achieving genomewide significance in the corresponding ASD GWAS (±500kb), 10 of which surround the 17q21 inversion. Five of the 10 significant genes surrounding the 17q21 inversion are also identified as significantly associated using the functionally agnostic region-based approach employed by MAGMA, of which several were previously reported by Grove and colleagues (4) . The inversion at 17q21, which has a population frequency of around 20% in Europeans, has been previously highlighted as an ASD susceptibility locus through linkage analysis (29) and family-based GWAS (30) . The 900kb inverted region, which contains many known genes, is marked by extensive LD, complicating identification of the causal susceptibility genes. One study used a fine mapping approach and implicated CACNA1G as a ASD susceptibility gene in the region (31) . Results from our TWAS show no evidence of association between ASD and CACNA1G expression (p = 0.33 based on CMC Prefontal Cortex). Expression of several other genes mapping to this region have recently been implicated in the personality trait of neuroticism (12) .
The only locus containing a transcriptome-wide significant gene that is not significantly implicated by either GWAS or MAGMA was PDIA6 on chromosome 2. This discovery highlights the advantage of TWAS which incorporates additional functional information of genetic variants as opposed to relying purely on the proximity of SNPs to a gene.
Previous studies using the TWAS approach commonly report associations as novel if the associated feature is outside of genome-wide significant loci in the corresponding GWAS (11, 32) . However,
given that TWAS is a gene-based approach, it gains power both from incorporating functional annotations but also by pooling evidence across multiple genetic variants. Therefore, we have compared the TWAS results to those from the functionally agnostic gene-based approach employed in MAGMA (and other software) to more clearly distinguish the novel insights that TWAS can provide.
This comparison demonstrated that four of the five regions containing independent ASD TWAS associations also contained significant associations identified by the functionally agnostic approach, suggesting that it is often pooling information across genetic variants that highlights regions of novel association. However, the genes that were implicated within these regions often differed between the two gene-based approaches. A key advantage of TWAS is that it considers the functional annotations of associated genetic variants and can therefore provide mechanistic insight into how a regional association is mediated. This is valuable information for subsequent experimental studies that aim to understand the mechanism underlying the genetic association, and could also be used to improve (36) . These previous findings suggest that differential expression of CTSB leads to several differences in neurogenesis and neuronal cell death, and therefore is a plausible candidate for ASD.
Cathepsin B is also an amyloid precursor protein secretase, and inhibition of it has been reported as a potential therapeutic for Alzheimer's disease (38) . This is interesting given prior evidence of shared aetiology between ASD and Alzheimer's disease (39) . Table 2 . List of independent transcriptome-wide significant loci.
